Interchange Capital Partners LLC Trims Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Interchange Capital Partners LLC reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 19.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 948 shares of the medical equipment provider’s stock after selling 233 shares during the quarter. Interchange Capital Partners LLC’s holdings in Intuitive Surgical were worth $490,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Howard Capital Management Group LLC boosted its holdings in shares of Intuitive Surgical by 4.5% during the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock valued at $1,044,000 after buying an additional 92 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in shares of Intuitive Surgical by 1.5% during the 3rd quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock valued at $295,938,000 after buying an additional 9,194 shares in the last quarter. Quest Partners LLC bought a new stake in shares of Intuitive Surgical during the 3rd quarter valued at $173,000. Stonebrook Private Inc. bought a new stake in shares of Intuitive Surgical during the 3rd quarter valued at $225,000. Finally, Nicolet Advisory Services LLC boosted its holdings in shares of Intuitive Surgical by 7.3% during the 3rd quarter. Nicolet Advisory Services LLC now owns 1,024 shares of the medical equipment provider’s stock valued at $491,000 after buying an additional 70 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of brokerages recently issued reports on ISRG. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Wells Fargo & Company upped their price target on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Citigroup upped their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Finally, Erste Group Bank lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $611.86.

Intuitive Surgical Price Performance

ISRG stock opened at $492.49 on Monday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a market capitalization of $175.41 billion, a price-to-earnings ratio of 76.83, a PEG ratio of 5.85 and a beta of 1.43. The business has a 50 day simple moving average of $562.24 and a two-hundred day simple moving average of $532.03.

Insider Activity

In other news, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, February 10th. The shares were sold at an average price of $590.00, for a total value of $158,710.00. Following the transaction, the chief financial officer now owns 3,282 shares in the company, valued at approximately $1,936,380. This represents a 7.58 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.